Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun 14;17(6):e85992.
doi: 10.7759/cureus.85992. eCollection 2025 Jun.

Challenges and Strategies in Medication Management for Patients With Multiple Comorbidities

Affiliations
Review

Challenges and Strategies in Medication Management for Patients With Multiple Comorbidities

Ayomide H Adeyemi et al. Cureus. .

Abstract

As the global population ages, polypharmacy-the concurrent use of multiple medications-has become increasingly common among older adults with multiple chronic conditions. While often clinically necessary, polypharmacy is associated with significant challenges, including medication nonadherence, adverse drug events, and increased hospitalizations. This narrative review synthesizes current evidence to explore the burden of polypharmacy, identify barriers to safe medication use, and assess intervention strategies aimed at improving outcomes in older adults. Drawing from diverse sources including clinical trials, observational studies, and policy reports, this review highlights the multifaceted nature of medication management in older adults. Contributing factors to nonadherence include cognitive decline, regimen complexity, low health literacy, and fragmented care. Interventions such as pharmacist-led medication reviews, deprescribing initiatives, motivational interviewing, and digital health tools have demonstrated potential in improving adherence and therapeutic safety. Emerging approaches-including pharmacogenomic-guided prescribing and AI-driven clinical decision support-also offer promising avenues for personalized care. A comprehensive, multidisciplinary framework that incorporates patient-centered communication, integrated care models, and supportive policy infrastructure is essential for addressing the complexities of polypharmacy in older populations. Continued research and collaboration across healthcare disciplines will be critical to translating these strategies into routine practice and enhancing medication safety for this vulnerable demographic.

Keywords: artificial intelligence in healthcare; collaborative approach; deprescribing; digital health education; medication adherence; medication management; multimorbidity management; older adult; pharmacogenomics; polypharmacy.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Figures

Figure 1
Figure 1. Polypharmacy management framework
A visual summary of patient-centered strategies to manage polypharmacy in older adults with multimorbidity. Created by the author for this publication. No external sources were used.

Similar articles

References

    1. Polypharmacy among adults aged 65 years and older in the United States: 1988-2010. Charlesworth CJ, Smit E, Lee DS, et al. J Gerontol A Biol Sci Med Sci. 2015;70:989–995. - PMC - PubMed
    1. Decade of healthy ageing: baseline report. [ Jun; 2025 ]. 2021. https://www.who.int/publications/i/item/9789240017900 https://www.who.int/publications/i/item/9789240017900
    1. Organisation for Economic Co-operation and Development (OECD) (data drawn from Fig. Paris: OECD Publishing; [ Jun; 2025 ]. 2023. Health at a Glance 2023: OECD Indicators.
    1. An update on the clinical consequences of polypharmacy in older adults: a narrative review. Wastesson JW, Morin L, Tan EC, et al. Expert Opin Drug Saf. 2018;17:1185–1196. - PubMed
    1. Clinical consequences of polypharmacy in elderly. Maher RL, Hanlon J, Hajjar ER. Expert Opin Drug Saf. 2014;13:57–65. - PMC - PubMed

LinkOut - more resources